| Serial Number | 90474748 |
| Word Mark | GALXC PLUS |
| Filing Date | Tuesday, January 19, 2021 |
| Status | 688 - NOTICE OF ALLOWANCE - ISSUED |
| Status Date | Tuesday, March 12, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, January 16, 2024 |
| Description of Mark | The mark consists of the words "GALXC PLUS" in stylized font, with "GAL" and "PLUS" in blue title font and "XC" in enlarged orange capital letters. The orange letter "X" in "GALXC PLUS" is partially composed of a repeating pattern of light, medium and dark orange shaded triangles. |
| Goods and Services | Oligonucleotide compounds for use in targeted pharmaceutical therapies for the treatment of rare diseases, genetic disorders, cardiovascular diseases, and viral infections; Oligonucleotide delivery agents consisting of compounds that facilitate the delivery of a wide range of pharmaceutical and therapeutic agents intravenously or subcutaneously for use in targeted pharmaceutical therapies for the treatment of rare diseases, genetic disorders, cardiovascular diseases, and viral infections; Oligonucleotide compounds for use in the targeted delivery of RNA interference (RNAi) therapy; Oligonucleotide delivery agents consisting of compounds that facilitate the delivery of a wide range of pharmaceutical and therapeutic agents intravenously or subcutaneously for use in targeted pharmaceutical therapies for a wide range of medical purposes; drug delivery agents consisting of oligonucleotide compounds that facilitate the delivery of a wide range of pharmaceutical based therapies |
| Pseudo Mark | GALAXY PLUS |
| Indication of Colors claimed | The color(s) blue and orange is/are claimed as a feature of the mark. |
| Goods and Services | Research and development of oligonucleotide compounds for use in targeted pharmaceutical therapies for the treatment of rare diseases, genetic disorders, cardiovascular diseases, and viral infections; research and development of pharmaceutical preparations for the treatment of disorders outside the liver; research and development of oligonucleotide compounds for targeted gene silencing; research and development of oligonucleotide drug delivery platforms for use in the treatment of rare diseases, genetic disorders, cardiovascular diseases, and viral infections |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, April 20, 2021 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, April 20, 2021 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Dicerna Pharmaceuticals, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Lexington, MA 02421 |
| Party Name | Dicerna Pharmaceuticals, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Lexington, MA 02421 |
| Event Date | Event Description |
| Tuesday, March 12, 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, January 16, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, January 16, 2024 | PUBLISHED FOR OPPOSITION |
| Wednesday, December 27, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Wednesday, December 13, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Friday, November 10, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, November 10, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, November 10, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, August 10, 2023 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
| Thursday, August 10, 2023 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| Thursday, May 11, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, May 11, 2023 | NON-FINAL ACTION E-MAILED |
| Thursday, May 11, 2023 | NON-FINAL ACTION WRITTEN |
| Thursday, April 6, 2023 | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION |
| Tuesday, February 7, 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Tuesday, February 7, 2023 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Tuesday, February 7, 2023 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Wednesday, September 7, 2022 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED |
| Wednesday, May 25, 2022 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Wednesday, May 25, 2022 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Wednesday, May 25, 2022 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Monday, March 7, 2022 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED |
| Wednesday, February 2, 2022 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Wednesday, February 2, 2022 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Wednesday, February 2, 2022 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Thursday, January 13, 2022 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Thursday, January 13, 2022 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Thursday, January 13, 2022 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Wednesday, January 5, 2022 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Wednesday, January 5, 2022 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Wednesday, January 5, 2022 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Wednesday, January 5, 2022 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Wednesday, January 5, 2022 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Tuesday, August 31, 2021 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Tuesday, August 31, 2021 | LETTER OF SUSPENSION E-MAILED |
| Tuesday, August 31, 2021 | SUSPENSION LETTER WRITTEN |
| Thursday, August 12, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, August 12, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, August 12, 2021 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, July 27, 2021 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, July 27, 2021 | NON-FINAL ACTION E-MAILED |
| Tuesday, July 27, 2021 | NON-FINAL ACTION WRITTEN |
| Tuesday, July 20, 2021 | ASSIGNED TO EXAMINER |
| Tuesday, April 20, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, February 25, 2021 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Thursday, February 25, 2021 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Thursday, February 25, 2021 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Friday, January 22, 2021 | NEW APPLICATION ENTERED |